These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10375727)

  • 1. Pyruvate-based peritoneal dialysate preserves neutrophilic oxygen consumption.
    Zhou FQ; Yu AW
    Zhongguo Yao Li Xue Bao; 1998 May; 19(3):207-10. PubMed ID: 10375727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyruvate improves neutrophilic nitric oxide generation in peritoneal dialysis solutions.
    Wu YT; Wu ZL; Jiang XF; Li S; Zhou FQ
    Artif Organs; 2005 Dec; 29(12):976-80. PubMed ID: 16305654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advantages of pyruvate over lactate in peritoneal dialysis solutions.
    Zhou FQ
    Acta Pharmacol Sin; 2001 May; 22(5):385-92. PubMed ID: 11743883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate anions neutralize peritoneal dialysate cytotoxicity.
    Mahiout A; Brunkhorst R
    Nephrol Dial Transplant; 1995; 10(3):391-4. PubMed ID: 7792037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutrophilic transient acidification and superoxide production in peritoneal dialysate.
    Zhou FQ; Zhou XJ; Yu AW; Song RH
    Chin Med Sci J; 1999 Dec; 14(4):215-9. PubMed ID: 12894894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyruvate preserves neutrophilic superoxide production in acidic, high glucose-enriched peritoneal dialysis solutions.
    Wu YT; Wu ZL; Jiang XF; Li S; Zhou FQ
    Artif Organs; 2003 Mar; 27(3):276-81. PubMed ID: 12662215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lactate-based and bicarbonate-based peritoneal dialysis solutions on neutrophilic oxygen consumption.
    Ing TS; Huie DA; Johnson V; Ryu J; Yu AW; Wong FK; Zhou FQ
    Artif Organs; 1995 May; 19(5):440-2. PubMed ID: 7625924
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of an acidic, lactate-based peritoneal dialysis solution and its euhydric, bicarbonate-based counterpart on neutrophilic intracellular pH.
    Zhou XJ; Yu AW; Zhou FQ; Ryu J; Ing TS; Vaziri ND
    Int J Artif Organs; 1993 Dec; 16(12):816-9. PubMed ID: 8175196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of dialysate on peritoneal phagocyte oxidative metabolism.
    Topley N; Alobaidi HM; Davies M; Coles GA; Williams JD; Lloyd D
    Kidney Int; 1988 Sep; 34(3):404-11. PubMed ID: 3172649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of an pyruvate-based peritoneal dialysis solution on the pH of a residual peritoneal dialysis fluid.
    Ing TS; Yang ML; Yang VL; Wong FK; Cheng YL; Guddeti SR; Yu AW
    Artif Organs; 1996 Mar; 20(3):264-6. PubMed ID: 8694698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M; Endoh M; Suzuki D; Tanabe R; Endoh H; Hirahara I; Sakai H
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biocompatibility pattern of a bicarbonate/lactate-buffered peritoneal dialysis fluid in APD: a prospective, randomized study.
    Fusshoeller A; Plail M; Grabensee B; Plum J
    Nephrol Dial Transplant; 2004 Aug; 19(8):2101-6. PubMed ID: 15213322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneal dialysis solutions disturb the balance of apoptosis and proliferation of peritoneal cells in chronic dialysis model.
    Zheng Z; Ye R; Yu X; Bergström J; Lindholm B
    Adv Perit Dial; 2001; 17():53-7. PubMed ID: 11510297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of ginsenosides on human peritoneal mesothelial cell against lactate-based peritoneal dialysis solutions--induced injury in vitro].
    Ye Y; Peng YM; Liu FY
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):317-20. PubMed ID: 12536722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bicarbonate/lactate peritoneal dialysis solutions on human mesothelial cell proliferation ex vivo.
    Bajo MA; del Peso G; Castro MA; Díaz C; Castro MJ; Gil F; Sánchez-Tomero JA; Selgas R
    Adv Perit Dial; 2001; 17():37-41. PubMed ID: 11510293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophilic intracellular acidosis induced by conventional, lactate-containing peritoneal dialysis solutions.
    Yu AW; Zhou XJ; Zhou FQ; Nawab ZM; Gandhi VC; Ing TS; Vaziri ND
    Int J Artif Organs; 1992 Nov; 15(11):661-5. PubMed ID: 1490758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of pH-neutral peritoneal dialysis solution.
    Moriishi M; Kawanishi H; Kawai T; Takahashi S; Hirai T; Shishida M; Watanabe H; Takahashi N
    Adv Perit Dial; 2002; 18():68-71. PubMed ID: 12402590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved biocompatibility of bicarbonate/lactate-buffered PDF is not related to pH.
    Zareie M; Keuning ED; ter Wee PM; Schalkwijk CG; Beelen RH; van den Born J
    Nephrol Dial Transplant; 2006 Jan; 21(1):208-16. PubMed ID: 16263741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The alteration of dialysate cancer antigen 125 concentration under a biocompatible bicarbonate peritoneal dialysis solution and the preservation of the mesothelial cell viability.
    Theodoridis M; Passadakis P; Kriki P; Gioka T; Panagoutsos S; Mourvati E; Thodis E; Kantartzi K; Vargemezis V
    Ren Fail; 2008; 30(2):161-7. PubMed ID: 18300115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of peritoneal dialysis solution on proliferation and apoptosis of rat peritoneal mesothelial cells].
    Chen SX; Ren H; Liu ZR; Liu HF
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1276-9. PubMed ID: 16982434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.